Scipher Medicine
Biotechnology ResearchMassachusetts, United States51-200 Employees
Scipher Medicine is a biotechnology research company based in Burlington, Massachusetts. It is developing a molecular diagnostic platform designed to predict which drug will be effective for a patient by analyzing the underlying biology of their disease, rather than relying on symptoms or traditional disease classifications. The test generates molecular data that can be used to guide treatment decisions and to inform the discovery of new therapeutic targets for patients who do not respond to existing therapies. The company serves clinicians and healthcare systems seeking to improve treatment outcomes by selecting the most effective therapy from the outset and reducing wasted drugs. It positions itself in the field of precision immunology and is expanding its reach through partnerships and international initiatives, including efforts to bring its rheumatoid arthritis test, PrismRA, to Colombia. The organization maintains a mid-sized workforce and continues to build collaborations to advance its tests and associated research.